Antiprotozoal Drug Access

The global antiprotozoal drugs market is experiencing significant growth, driven by the rising burden of diseases like malaria and leishmaniasis.

Malaria remains the most prevalent, with an estimated 249 million cases in 2022. Other major targets include Chagas disease, leishmaniasis, giardiasis, and trichomoniasis. antiprotozoal drug

Antiprotozoal drugs are a class of medications specifically designed to treat infections caused by protozoa—single-celled eukaryotic organisms. These drugs are critical for managing diseases that primarily affect tropical and subtropical regions, impacting over annually. Market and Clinical Landscape Antiprotozoal drugs are a class of medications specifically

Over 60% of prescriptions are issued in lower-middle-income economies, with India and China manufacturing roughly 72% of the global generic supply for key drugs like metronidazole. Common Drugs and Their Applications Common Drugs and Their Applications Antiprotozoals are often

Antiprotozoals are often categorized into and other antiprotozoal drugs .

Compounds such as Metronidazole , Atovaquone, and Benznidazole continue to lead treatment protocols.